Serum lysozyme: A potential marker of monocyte/macrophage activity in rheumatoid arthritis

Rheumatology

Volumn 38, Issue 12, 1999, Pages 1249-1254

  Torsteinsdottir I ^a,b   Hakansson L ^a   Hallgren R ^a   Gudbjornsson B ^a   Arvidson, N G ^a   Venge, P ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b Department of Clinical Biochemistry ^*  (Iceland)

Author keywords

Lysozyme; Myeloperoxidase; Prednisolone; Rheumatoid arthritis

Indexed keywords

HYDROCORTISONE; LACTOFERRIN; LIPOCALIN; LYSOZYME; METYRAPONE; MYELOPEROXIDASE; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; AGED; ARTICLE; CELL ACTIVITY; CELL SECRETION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HUMAN; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR PHAGOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS;

EID: 0032786025     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.12.1249     Document Type: Article

References (34)

1. Rappolee DA, Werb Z. Secretory products of phagocytes. Curr Opin Immunol 1988;1:47-55.
2. Cutolo M, Sulli A, Barone A, Seriolo B, Accardo S, Macrophages, synovial tissue and rheumatoid arthritis. Clin Exp Rheumatol 1993;11:331-9.
3. Yanni G, Whelan A, Feighery C, Bresnihan B. Synovial tissue macrophages and joint erosion in rheumatoid arthritis. Ann Rheum Dis 1994;53:39-44.
4. Elsbach P, Weiss J. Oxygen-independent antimicrobial systems of phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation. Basic principles and clinical correlates, 2nd edn. New York: Raven Press, 1992:603-36.
5. Hansen NE. Lysozyme in haematology. Pathophysiology and clinical use. Scand J Haematol 1975;14:160-5.
6. Lappin D, Hamilton AD, Morrison L, Aref M, Whaley K. Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages. J Clin Lab Immunol 1986;20:101-5.
7. Lewis CE, McCarthy SP, Lorenzen J, McGce JO. Differential effects of LPS, IFN-gamma and TNF-alpha on the secretion of lysozyme by individual human mononuclear phagocytes: relationship to cell maturity. Immunology 1990;69:402-8.
8. Panarelli M, Holloway CD, Mulatero P, Fraser R. Inhibition of lysozyme synthesis by dexamethasone in human mononuclear leukocytes: an index of glucocorticoid sensitivity. J Clin Endocrinol Metab 1994;78:872-7.
9. Pruzanski W, Saito S, Ogryzlo MA. The significance of lysozyme (muramidase) in rheumatoid arthritis. Arthritis Rheum 1970;13:389-99.
10. Malmquist J, Thorell JI, Wolheim FA. Lactoferrin and lysozyme in arthritic exudates. Acta Med Scand 1977;202:313-8.
11. Bennett RM, Skoscy JL. Lactoferrin and lysozyme levels in synovial fluid. Differential indices of articular inflammation and degradation. Arthritis Rheum 1977;20:84-90.
12. Marino I, Columbo M, Marone G. The releasability of lysosomal enzymes from neutrophil leukocytes in patients with rheumatoid arthritis. Clin Exp Rheumatol 1996; 14:387-94.
13. Haneberg B, Glette J, Talstad I, Sörnes S, Solberg CO. In vitro release of lysozyme from monocytes and granulocytes. J Leukocyte Biol 1984;35:573-82.
14. Resnitzky P, Shaft D, Yaari A, Nir E. Distinct intracellular lysozyme content in normal granulocytes and monocytes: A quantitative immunoperoxidase and ultrastructural immunogold study. J Histochem Cytochem 1994; 42:1471-7.
15. Venge P. The monitoring of inflammation by specific cellular markers. Scand J Clin Lab Invest 1994;54(Suppl. 219):47-54.
16. Hansen NE, Karle H. Elevated plasma lysozyme in Hodgkin's disease. An indicator of increased macrophage activity? Scand J Haematol 1979;22:173-8.
17. van Furth R. Development and distribution of mononuclear phagocytes. In: Gallin JI, Goldstein IM, Snyderman R, eds. Inflammation. Basic principles and clinical correlates, 2nd edn. New York: Raven Press, 1992;325-51.
18. Reiter B. The biological significance of lactoferrin. Int J Tissue React 1983;5:87-96.
19. Xu SY, Carlson M, Engström Å, Garcia R, Peterson CG, Venge P. Purification and characterization of a human neutrophil lipocalin (HNL) from the secondary granules of human neutrophils. Scand J Clin Lab Invest 1994;54:365-76.
20. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425-32.
21. Hench P, Kendall EC, Slocumb CH, Polley HF. The effect of a hormone of the adrenal cortex and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proc Mayo Clin 1949;24:181-97.
22. Kirwan JR. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. The Arthritis and Rheumatism Council Low-dose Glucocorticoid Study Group. N Engl J Mcd 1995;333:142-6.
23. Boumpas DT, Chrousos GP, Wilder RL, Cupps TR, Balow JE. Glucocorticoid therapy for immune-mediated diseases: basic and clinical correlates. Ann Intern Med 1993;119:1198-208.
24. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
25. Thompson PW, Silman AJ, Kirwan JR, Currey HL. Articular indices of joint inflammation in rheumatoid arthritis. Arthritis Rheum 1987;30:618-23.
26. Xu SY, Peterson CG, Carlson M, Venge P. The development of an assay for human neutrophil lipocalin (HNL) to be used as a specific marker of neutrophil activity in vivo and vitro. J Immunol Methods 1994;171:245-52.
27. Olofsson T, Olsson I, Venge P, Elgefors B. Serum myeloperoxidase and lactoferrin in neutropenia. Scand J Haematol 1977;18:73-80.
28. Liote F, Boval-Boizard B, Weill D, Kuntz D, Wautier JL. Blood monocyte activation in rheumatoid arthritis: increased monocyte adhesiveness, integrin expression, and cytokine release. Clin Exp Immunol 1996;106:13-9.
29. Mazure G, Fernandes T, McCarthy DA, Maccy M, Perry JD, Taub NA et al. Blood monocytes in rheumatoid arthritis are highly adherent to cultured endothelium. Int Arch Allergy Immunol 1995;108:211-23.
30. Torsteinsdottir I, Arvidson NG, Hallgren R, Håkansson L. Monocyte activation in rheumatoid arthritis: increased integrin. Fc-gamma and complement receptor expression and the effect of glucocorticoids. Clin Exp Immunol 1999;115:554-60.
31. Bajaj MS, Kew RR, Webster RO, Hyers TM. Priming of human neutrophil functions by tumor necrosis factor: Enhancement of Superoxide anion generation, degranulation and chemotaxis to chemoattractants C5a and F-Met-Leu-Phe. Inflammation 1992;16:241-50.
32. Manicourt DH, Triki R, Fukuda K, Devogelaer JP, Nagant de Deuxchaisnes C, Thonar EJ. Levels of circulating tumor necrosis factor alpha and interleukin-6 in patients with rheumatoid arthritis. Relationship to serum levels of hyaluronan and antigenic keratan sulfate. Arthritis Rheum 1993;36:490-9.
33. Lappin DF, Whaley K. Modulation of complement gene expression by glucocorticoids. Biochem J 1991;280:117-23.
34. Finkelstein AE, Roisman FR, Walz DT. Effect of auranofin, a new antiarthritic agent, on immune complex-induced release of lysosomal enzymes from human leukocytes. Inflammation 1977;2:143-50.